litlas
Log inCreate account

Ulf‐Håkan Stenman

Active 1976–2023

Also published as
Ulf-Håkan Stenman
102
Papers
18,046
Citations
82
h-index
102
i10-index

Citations

Citations per year for Ulf‐Håkan Stenman1973: 1 citations1975: 1 citations1976: 3 citations1979: 2 citations1980: 1 citations1982: 3 citations1983: 2 citations1984: 6 citations1985: 5 citations1986: 9 citations1987: 8 citations1988: 10 citations1989: 13 citations1990: 10 citations1991: 17 citations1992: 19 citations1993: 16 citations1994: 20 citations1995: 37 citations1996: 52 citations1997: 47 citations1998: 51 citations1999: 66 citations2000: 82 citations2001: 82 citations2002: 76 citations2003: 107 citations2004: 122 citations2005: 119 citations2006: 126 citations2007: 132 citations2008: 140 citations2009: 103 citations2010: 111 citations2011: 97 citations2012: 102 citations2013: 135 citations2014: 138 citations2015: 142 citations2016: 96 citations2017: 76 citations2018: 87 citations2019: 259 citations2020: 254 citations2021: 247 citations2022: 183 citations2023: 138 citations2024: 225 citations2025: 82 citations2026: 2 citations1974: no citations, so this year is not shown1977–1978: no citations, so these years are not shown1981: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,294 citing papers, 24.5% of this breakdownUnited Kingdom: 409 citing papers, 7.7% of this breakdownGermany: 304 citing papers, 5.7% of this breakdownFinland: 303 citing papers, 5.7% of this breakdownChina: 302 citing papers, 5.7% of this breakdownCanada: 237 citing papers, 4.5% of this breakdownSweden: 236 citing papers, 4.5% of this breakdownNetherlands: 225 citing papers, 4.3% of this breakdownItaly: 195 citing papers, 3.7% of this breakdownFrance: 180 citing papers, 3.4% of this breakdownAustralia: 146 citing papers, 2.8% of this breakdownJapan: 114 citing papers, 2.2% of this breakdown
0%24.5%Other 25.3%

Institutions

Fields

  • Medicine70.3%
  • Biochemistry, Genetics and Molecular Biology19.6%
  • Immunology and Microbiology2.3%
  • Neuroscience1.6%
  • Chemistry1.4%
  • Engineering1%
  • Other3.8%

Topics

  • Prostate Cancer Treatment and Research8.9%
  • Prostate Cancer Diagnosis and Treatment8.9%
  • Protease and Inhibitor Mechanisms1.7%
  • Growth Hormone and Insulin-like Growth Factors1.6%
  • Global Cancer Incidence and Screening1.5%
  • Pregnancy and preeclampsia studies1.3%
  • Other76.1%

Coauthors

All papers

Open in search
  1. A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

    Authors: Jonas Hugosson, Monique J. Roobol, Marianne Månsson, Teuvo L.J. Tammela, Marco Zappa, Vera Nelen, Maciej Kwiatkowski, M. Luján, Sigrid Carlsson, Kirsi Talala, Hans Lilja, Louis Denis, Franz Recker, Álvaro Páez, Donella Puliti, Arnauld Villers, Xavier Rébillard, Tuomas P. Kilpeläinen, Ulf‐Håkan Stenman, Rebecka Arnsrud Godtman, Karin Stinesen Kollberg, Sue M. Moss, Paula Kujala, Kimmo Taari, Andreas Huber, Theodorus van der Kwast, Eveline A.M. Heijnsdijk, Chris Bangma, Harry J. de Koning, Fritz H. Schröder, Anssi Auvinen - European Urology 2019 cited by 698

  2. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

    Authors: Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, Teuvo L.J. Tammela, Marco Zappa, Vera Nelen, Maciej Kwiatkowski, M. Luján, Liisa Määttänen, Hans Lilja, Louis Denis, Franz Recker, Álvaro Páez, Chris H. Bangma, Sigrid Carlsson, Donella Puliti, Arnauld Villers, Xavier Rébillard, Matti Hakama, Ulf‐Håkan Stenman, Paula Kujala, Kimmo Taari, Gunnar Aus, Andreas Huber, Theodorus van der Kwast, Ron H. N. van Schaik, Harry J. de Koning, Sue Moss, Anssi Auvinen - The Lancet 2014 cited by 1,565

  3. Prostate-Cancer Mortality at 11 Years of Follow-up

    Authors: Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, Teuvo L.J. Tammela, Stefano Ciatto, Vera Nelen, Maciej Kwiatkowski, M. Luján, Hans Lilja, Marco Zappa, Louis Denis, Franz Recker, Álvaro Páez, Liisa Määttänen, Chris H. Bangma, Gunnar Aus, Sigrid Carlsson, Arnauld Villers, Xavier Rébillard, Theodorus van der Kwast, Paula Kujala, B. G. Blijenberg, Ulf‐Håkan Stenman, Andreas Huber, Kimmo Taari, M Hakama, Sue Moss, Harry J. de Koning, Anssi Auvinen - New England Journal of Medicine 2012 cited by 1,241

  4. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers

    Authors: Catharine M. Sturgeon, Michael J. Duffy, Ulf‐Håkan Stenman, Hans Lilja, Nils Brünner, Daniel W. Chan, Richard J. Babaian, Robert C. Bast, Barry L. Dowell, Francisco J. Esteva, Caj Haglund, Nadia Harbeck, Daniel F. Hayes, Mads Holten-Andersen, George G. Klee, R. Lamerz, Leendert H. J. Looijenga, Rafael Molina, Hans Jørgen Nielsen, Harry G. Rittenhouse, Axel Semjonow, Ie‐Ming Shih, Paul Sibley, György Sölétormos, Carsten Stephan, Lori J. Sokoll, Barry Hoffman, Eleftherios P. Diamandis - Clinical Chemistry 2008 cited by 1,134

  5. The classification, functions and clinical use of different isoforms of HCG

    Authors: Ulf‐Håkan Stenman, Aila Tiitinen, Henrik Alfthan, Leena Valmu - Human Reproduction Update 2006 cited by 219

  6. KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D

    Authors: Sawan Kumar Jha, Khushbu Rauniyar, Ewa Chronowska, Kenny Mattonet, Eunice Wairimu Maina, Hannu Koistinen, Ulf-Håkan Stenman, Kari Alitalo, Michael Jeltsch - eLife 2019 cited by 44

  7. A Nationwide Survey of Mortality in Acromegaly

    Authors: Ritva Kauppinen‐Mäkelin, Timo Sane, Antti Reunanen, Matti Välimäki, Leo Niskanen, Helene Markkanen, Eliisa Löyttyniemi, Tapani Ebeling, Pia Jaatinen, Hanna Laine, Pirjo Nuutila, Pasi Salmela, Jorma Salmi, Ulf‐Håkan Stenman, Jorma Viikari, Erkki Voutilainen - The Journal of Clinical Endocrinology & Metabolism 2005 cited by 269

  8. Increased Activity of the Hypothalamic-Pituitary-Testicular Axis in Infancy Results in Increased Androgen Action in Premature Boys

    Authors: Tanja Kuiri‐Hänninen, Raija Seuri, Erja Tyrväinen, Ursula Turpeinen, Esa Hämäläinen, Ulf‐Håkan Stenman, Leo Dunkel, Ulla Sankilampi - The Journal of Clinical Endocrinology & Metabolism 2010 cited by 195

  9. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer

    Authors: Camilla Böckelman, Ines Beilmann‐Lehtonen, Tuomas Kaprio, Selja Koskensalo, Taina Tervahartiala, Harri Mustonen, Ulf‐Håkan Stenman, Timo Sorsa, Caj Haglund - BMC Cancer 2018 cited by 96

  10. The roles of proteases in prostate cancer

    Authors: Hannu Koistinen, Ruusu‐Maaria Kovanen, Morley D. Hollenberg, Antoine Dufour, Evette S. Radisky, Ulf‐Håkan Stenman, Jyotsna Batra, Judith A. Clements, John D. Hooper, Eleftherios P. Diamandis, Oliver Schilling, Antti Rannikko, Tuomas Mirtti - IUBMB Life 2023 cited by 37

  11. Human chorionic gonadotropin in cancer

    Authors: Ulf‐Håkan Stenman, Henrik Alfthan, Kristina Hotakainen - Clinical Biochemistry 2004 cited by 288

  12. Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer

    Authors: Katri A. Leinonen, Outi R. Saramäki, Bungo Furusato, Takahiro Kimura, Hiroyuki Takahashi, Shin Egawa, Hiroyoshi Suzuki, Kerri Keiger, Sung Ho Hahm, William B. Isaacs, Teemu Tolonen, Ulf‐Håkan Stenman, Teuvo L.J. Tammela, Matti Nykter, G. Steven Bova, Tapio Visakorpi - Cancer Epidemiology Biomarkers & Prevention 2013 cited by 139

  13. Emerging Roles of SPINK1 in Cancer

    Authors: Kati Räsänen, Outi Itkonen, Hannu Koistinen, Ulf‐Håkan Stenman - Clinical Chemistry 2015 cited by 81

  14. Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma

    Authors: Anna Nurmi, Harri Mustonen, Ulf‐Håkan Stenman, Hanna Seppänen, Caj Haglund - Scientific Reports 2021 cited by 32

  15. Potent Inhibitor of Human Trypsins from the Aeruginosin Family of Natural Products

    Authors: Muhammad N. Ahmed, Matti Wahlsten, Jouni Jokela, Matthias Nees, Ulf‐Håkan Stenman, Danillo Oliveira Alvarenga, Tomas Strandin, Kaarina Sivonen, Antti Poso, Perttu Permi, Mikko Metsä‐Ketelä, Hannu Koistinen, David P. Fewer - ACS Chemical Biology 2021 cited by 30

  16. Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women

    Authors: Elina Keikkala, Janina Forstén, Olli Ritvos, Ulf‐Håkan Stenman, Eero Kajantie, Esa Hämäläinen, Katri Räikkönen, Pia Villa, Hannele Laivuori - Pregnancy Hypertension 2021 cited by 17

  17. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.

    Authors: Ulf‐Håkan Stenman, Jari Leinonen, Henrik Alfthan, S. Rannikko, Kari Tuhkanen, O Alfthan - 1991 cited by 939

  18. Tumor Necrosis Factor as a Potent Inhibitor of Adrenocorticotropin-Induced Cortisol Production and Steroidogenic P450 Enzyme Gene Expression in Cultured Human Fetal Adrenal Cells*

    Authors: Marja Jäättelä, V Ilvesmäki, Raimo Voutilainen, Ulf‐Håkan Stenman, E Saksela - Endocrinology 1991 cited by 250

  19. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.

    Authors: Monika Carpelan‐Holmström, Johanna Louhimo, Ulf‐Håkan Stenman, Henrik Alfthan, Caj Haglund - 2002 cited by 222

  20. Prostate-specific antigen

    Authors: Ulf‐Håkan Stenman, Jari Leinonen, Wanming Zhang, Patrik Finne - Seminars in Cancer Biology 1999 cited by 209

  21. Placental 11β-Hydroxysteroid Dehydrogenase-2 and Fetal Cortisol/Cortisone Shuttle in Small Preterm Infants

    Authors: Eero Kajantie, Leo Dunkel, Ursula Turpeinen, Ulf‐Håkan Stenman, Peter J. Wood, Mika Nuutila, Sture Andersson - The Journal of Clinical Endocrinology & Metabolism 2003 cited by 187

  22. Prostate Cancer Mortality in the Finnish Randomized Screening Trial

    Authors: Tuomas P. Kilpeläinen, Teuvo L.J. Tammela, Nea Malila, M Hakama, Henrikki Santti, Liisa Määttänen, Ulf‐Håkan Stenman, Paula Kujala, Anssi Auvinen - JNCI Journal of the National Cancer Institute 2013 cited by 112

  23. Rye Whole Grain and Bran Intake Compared with Refined Wheat Decreases Urinary C-Peptide, Plasma Insulin, and Prostate Specific Antigen in Men with Prostate Cancer1–3

    Authors: Rikard Landberg, Swen‐Olof Andersson, Jie‐Xian Zhang, Jan‐Erik Johansson, Ulf‐Håkan Stenman, Herman Adlercreutz, Afaf Kamal‐Eldin, Per Åman, Göran Hallmans - Journal of Nutrition 2010 cited by 95

  24. The Role of SPINK1 in ETS Rearrangement-Negative Prostate Cancers

    Authors: Scott A. Tomlins, Daniel R. Rhodes, Jianjun Yu, Sooryanarayana Varambally, Rohit Mehra, Sven Perner, Francesca Demichelis, Beth E. Helgeson, Bharathi Laxman, David S. Morris, Qi Cao, Xuhong Cao, Ove Andrén, Katja Fall, Laura A. Johnson, John T. Wei, Rajal B. Shah, Hikmat Al‐Ahmadie, James A. Eastham, Scott E. Eggener, Samson W. Fine, Kristina Hotakainen, Ulf‐Håkan Stenman, Alex Tsodikov, William L. Gerald, Hans Lilja, Victor E. Reuter, Phillip W. Kantoff, Peter T. Scardino, Mark A. Rubin, Anders Bjartell, Arul M. Chinnaiyan - Cancer Cell 2008 cited by 321